Background Pituitary dysfunction after brainstem death can cause various hormone
deficiencies in potential heart donors. The aim of this study was to evaluate the relationship …

Objective Heart transplantation (HT) is uniquely associated with the potential impact of
thyroid hormone therapy at three intersecting levels—donor, operation, and recipient. We …

Aims The aim of this study was to assess the haemodynamic effects of tri-iodothyronine (T3)
and methylprednisolone in potential heart donors. Methods and results In a prospective …

Objectives To investigate whether recipient administration of thyroid hormone (liothyronine
[T3]) is associated with reduced rates of primary graft dysfunction (PGD) after orthotopic …

Objective The effect of thyroid dysfunction on adverse outcomes has been studied in many
different patient populations. The objective of this study was to investigate the effect of …

Background Current risk-adjusted models used to predict donor heart use and cardiac graft
survival from organ donors after brain death (DBDs) do not include bedside critical care …

BACKGROUND Donor thyroid hormone (TH) supplementation therapy is widely used.
Recent reports suggested an increased risk of graft dysfunction in heart transplant (HTx) …

Background Acute hypothyroidism after brain death results in hemodynamic impairments
that limit availability of donor hearts. Thyroid hormone infusions can halt that process and …

Background Higher dose norepinephrine donor support is a frequent reason for donor heart
decline, but its associations with outcomes after heart transplantation are unclear. Methods …

Introduction During brain death, several events occur, including hormonal. metabolic and
systemic changes. This systematic review aims to find the role of hormone therapy in …